
Adult Vaccines Global Market Report 2025
Description
Adult Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on adult vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for adult vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adult vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Vaccine Type: Monovalent; Multivalent
2) By Technology: Live Attenuated Vaccines; Inactivated Viral Or Bacterial Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines
3) By Application: Influenza; DPT; Human Papillomavirus; Zoster; Pneumococcal; Hepatitis
4) By End Users: Healthcare Firms; Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines; Specific Disease Vaccines
2) By Multivalent: Combination Vaccines; Multi-Antigen Vaccines
Companies Mentioned: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on adult vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for adult vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adult vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Vaccine Type: Monovalent; Multivalent
2) By Technology: Live Attenuated Vaccines; Inactivated Viral Or Bacterial Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines
3) By Application: Influenza; DPT; Human Papillomavirus; Zoster; Pneumococcal; Hepatitis
4) By End Users: Healthcare Firms; Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines; Specific Disease Vaccines
2) By Multivalent: Combination Vaccines; Multi-Antigen Vaccines
Companies Mentioned: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Adult Vaccines Market Characteristics
- 3. Adult Vaccines Market Trends And Strategies
- 4. Adult Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Adult Vaccines Growth Analysis And Strategic Analysis Framework
- 5.1. Global Adult Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Adult Vaccines Market Growth Rate Analysis
- 5.4. Global Adult Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Adult Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Adult Vaccines Total Addressable Market (TAM)
- 6. Adult Vaccines Market Segmentation
- 6.1. Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monovalent
- Multivalent
- 6.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Live Attenuated Vaccines
- Inactivated Viral or Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
- 6.3. Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Influenza
- DPT
- Human Papillomavirus
- Zoster
- Pneumococcal
- Hepatitis
- 6.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Healthcare Firms
- Hospitals
- 6.5. Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single Antigen Vaccines
- Specific Disease Vaccines
- 6.6. Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Vaccines
- Multi-Antigen Vaccines
- 7. Adult Vaccines Market Regional And Country Analysis
- 7.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Adult Vaccines Market
- 8.1. Asia-Pacific Adult Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Adult Vaccines Market
- 9.1. China Adult Vaccines Market Overview
- 9.2. China Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Adult Vaccines Market
- 10.1. India Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Adult Vaccines Market
- 11.1. Japan Adult Vaccines Market Overview
- 11.2. Japan Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Adult Vaccines Market
- 12.1. Australia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Adult Vaccines Market
- 13.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Adult Vaccines Market
- 14.1. South Korea Adult Vaccines Market Overview
- 14.2. South Korea Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Adult Vaccines Market
- 15.1. Western Europe Adult Vaccines Market Overview
- 15.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Adult Vaccines Market
- 16.1. UK Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Adult Vaccines Market
- 17.1. Germany Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Adult Vaccines Market
- 18.1. France Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Adult Vaccines Market
- 19.1. Italy Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Adult Vaccines Market
- 20.1. Spain Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Adult Vaccines Market
- 21.1. Eastern Europe Adult Vaccines Market Overview
- 21.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Adult Vaccines Market
- 22.1. Russia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Adult Vaccines Market
- 23.1. North America Adult Vaccines Market Overview
- 23.2. North America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Adult Vaccines Market
- 24.1. USA Adult Vaccines Market Overview
- 24.2. USA Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Adult Vaccines Market
- 25.1. Canada Adult Vaccines Market Overview
- 25.2. Canada Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Adult Vaccines Market
- 26.1. South America Adult Vaccines Market Overview
- 26.2. South America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Adult Vaccines Market
- 27.1. Brazil Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Adult Vaccines Market
- 28.1. Middle East Adult Vaccines Market Overview
- 28.2. Middle East Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Adult Vaccines Market
- 29.1. Africa Adult Vaccines Market Overview
- 29.2. Africa Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Adult Vaccines Market Competitive Landscape And Company Profiles
- 30.1. Adult Vaccines Market Competitive Landscape
- 30.2. Adult Vaccines Market Company Profiles
- 30.2.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Commonwealth Serum Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
- 31. Adult Vaccines Market Other Major And Innovative Companies
- 31.1. Johnson & Johnson
- 31.2. Serum Institute of India
- 31.3. AstraZeneca PLC
- 31.4. Novartis AG
- 31.5. Protein Sciences Corporation
- 31.6. Emergent BioSolutions Inc.
- 31.7. Bavarian Nordic A/S
- 31.8. Dynavax Technologies Corporation
- 31.9. Novavax Inc
- 31.10. Medimmune LLC
- 31.11. BioNTech SE
- 31.12. Moderna
- 31.13. Inovio Pharmaceuticals
- 31.14. Sinovac
- 31.15. Valneva Se
- 32. Global Adult Vaccines Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Adult Vaccines Market
- 34. Recent Developments In The Adult Vaccines Market
- 35. Adult Vaccines Market High Potential Countries, Segments and Strategies
- 35.1 Adult Vaccines Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Adult Vaccines Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Adult Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.